ArticleClinical Medicine Insights. Oncology2026
Initial Low-Dose Dacomitinib for First-Line Treatment of Patients With EGFR Exon 21-Mutated Non-Small-Cell Lung Cancer.
Ke-Jun Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.